What is Sugarbreak?
Sugarbreak offers a non-prescription support system formulated with natural ingredients designed to help individuals curb sugar intake and manage blood sugar levels. The company is dedicated to combating the rising trends of obesity and diabetes, positioning itself as an alternative to the pharmaceutical complex by collaborating with scientists and clinicians to provide evidence-based solutions. Their approach emphasizes natural, effective, safe, and accessible blood sugar management, aiming to empower users to achieve optimal health.
How much funding has Sugarbreak raised?
Sugarbreak has raised a total of $3M across 1 funding round:
Other Financing Round
$3M
Other Financing Round (2020): $3M with participation from Bronze, BBG Ventures, SKAGEN Conscience Capital, and Sorven Capital
Key Investors in Sugarbreak
BBG Ventures
BBG Ventures is a venture capital firm that focuses on visionary entrepreneurs building next-generation consumer products and services, with a specific mandate to back companies founded by women. They invest in entrepreneurs leveraging technology to address common life challenges and transform daily habits.
Bronze
Undisclosed investor participating in the funding round.
SKAGEN Conscience Capital
Undisclosed investor participating in the funding round.
What's next for Sugarbreak?
The recent major strategic investment signals a pivotal growth phase for Sugarbreak, likely enabling the company to scale its operations, expand its product development, and broaden its market reach. This capital will be instrumental in furthering their research and clinical collaborations, reinforcing their commitment to evidence-based natural health solutions. Sugarbreak is poised to make a substantial impact on public health by addressing critical issues like sugar dependency, obesity, and diabetes.
See full Sugarbreak company page
